Hyperhemolysis in sickle cell disease

Journal of Pediatric Hematology/Oncology

Volumn 36, Issue 1, 2014, Pages

  Aragona, Elena ^a   Kelly, Michael J ^b  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Hemolysis; Hyperhemolysis; Sickle cell disease; Transfusion reaction

Indexed keywords

HEMOGLOBIN; HYDROXYUREA; IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; PREDNISONE;

ACUTE CHEST SYNDROME; ADULT; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; DRUG DOSE REDUCTION; DRUG MEGADOSE; ERYTHROCYTE TRANSFUSION; FATIGUE; FEMALE; HEADACHE; HEMATOLOGIC DISEASE; HEMATURIA; HEMOLYSIS; HUMAN; HYPERBILIRUBINEMIA; HYPERHEMOLYSIS; LABORATORY TEST; PRIORITY JOURNAL; RETICULOCYTOPENIA; SICKLE CELL ANEMIA; SYSTOLIC HEART MURMUR; THORAX PAIN; URINE COLOR;

EID: 84891836663     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31828e529f     Document Type: Article

References (15)

1. Win N, Doughty H, Telfer P, et al. Hyperhemolytic transfusion reaction in sickle cell disease. Transfusion. 2001;41:323-328
2. Petz LD, Calhoun L, Shulman IA, et al. The sickle cell hemolytic transfusion reaction syndrome. Transfusion. 1997; 37:382-392
3. Win N. Hyperhemolysis syndrome in sickle cell disease. Expert Rev Hematol. 2009;2:111-115
4. Petz LD. Bystander immune cytolysis. Transfus Med Rev. 2006;20:110-140
5. Schwartz RS, Tanaka Y, Fidler IJ, et al. Increased adherence of sickled and phosphatidylserine-enriched human erythrocytes to cultured human peripheral blood monocytes. J Clin Invest. 1985;75:1965-1972
6. Ballas SK, Marcolina MJ. Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia. Transfusion. 2006;46:105-110
7. Win N, New H, Lee E, et al. Hyperhemolysis syndrome in sickle cell disease: Case report (recurrent episode) and literature review. Transfusion. 2008;48:1231-1238
8. Lubin B, Chiu D, Bastacky J, et al. Abnormalities in membrane phospholipid organization in sickled erythrocytes. J Clin Invest. 1981;67:1643-1649
9. Ihanus E, Uotila LM, Toivanen A, et al. Red-cell ICAM-4 is a ligand for the monocyte/macrophage integrin CD11c/CD18: Characterization of the binding sites on ICAM-4. Blood. 2007;109:802-810
10. El-Husseini A, Sabry A. Fatal hyperhemolytic delayed transfusion reaction in sickle cell disease: A case report and literature review. Am J Emerg Med. 2010;28:1062.e5-1062.e8
11. Friedman D, Kim H, Manno C. Hyperhemolysis associated with red cell transfusion in sickle cell disease. Transfusion. 1993;33S:14
12. Talano J-AM, Hillery CA, Gottschall JL, et al. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. Pediatrics. 2003;111(pt 1):e661-e665
13. Rhoades CJ, Williams MA, Kelsey SM, et al. Monocytemacrophage system as targets for immunomodulation by intravenous immunoglobulin. Blood Rev. 2000;14:14-30
14. Bachmeyer C, Maury J, Parrot A, et al. Rituximab as an effective treatment of hyperhemolysis syndrome in sickle cell anemia. Am J Hematol. 2010;85:91-92
15. Noizat-Pirenne F, Bachir D, Chadebech P, et al. Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease. Haematologica. 2007;92:e132-e135